Harold J. Burstein, MD, PhD, breast oncologist, Dana-Farber Cancer Institute; professor of medicine, Harvard Medical School, Boston.<\/p>\n
Matthew J. Piotrowski, MD, assistant professor of breast surgical oncology and fellowship program associate director, Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston.<\/p>\n
Marina Sharifi, MD, PhD, fellow, hematology, medical oncology, and palliative care, University of Wisconsin Carbone Cancer Center, Madison.<\/p>\n
Kari B. Wisinski, MD, interim division chief, hematology, medical oncology, and palliative care; co-lead, Breast Disease-Oriented Team, University of Wisconsin Carbone Cancer Center, Madison.<\/p>\n
Yuan Yuan, MD, PhD, breast oncologist and associate professor of medical oncology and therapeutics research, City of Hope Cancer Center, Duarte, CA.<\/p>\n
American Cancer Society: \"How Common Is Breast Cancer?\" \"Survival Rates for Breast Cancer,\" \"Targeted Drug Therapy for Breast Cancer,\"<\/p>\n
\"Breast Cancer Facts & Figures 2019-2020.\"<\/p>\n
National Cancer Institute: \"Advances in Breast Cancer Research,\" \"Breast Cancer Screening.\"<\/p>\n
Mayo Clinic: \"Diagnosing breast cancer\" \"HER2-positive breast cancer: What is it?\" \"Paget's Disease of the Breast.\"<\/p>\n
MD Anderson Cancer Center: \"6 advances in breast cancer diagnosis and treatment.\"<\/p>\n
Breastcancer.org: \"Tumor Genomic Assays.\"<\/p>\n
Clinical Advances in Hematology and Oncology: \"Advances in the Treatment of Early-Stage HER2-Positive Breast Cancer.\"<\/p>\n
National Comprehensive Cancer Network: \"Genetic\/Familial High-Risk Assessment: Breast and Ovarian. 2019.''<\/p>\n
Journal of the National Cancer Institute: \"Changes in Mammography Use by Women's Characteristics During the First 5 Months of the COVID-19 Pandemic.\"<\/p>\n
OpenNotes.org: \"Federal Rules Mandating Open Notes.\"<\/p>\n
<\/p>\n
Here is the original post:<\/p>\n
Breast Cancer 2021: Much Progress, But Work Remains - WebMD<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Harold J. Burstein, MD, PhD, breast oncologist, Dana-Farber Cancer Institute; professor of medicine, Harvard Medical School, Boston. Matthew J Continue reading